Sanofi and GSK announced on 14 April 2020 that they will work together on the development of a new, adjuvanted vaccine for COVID-19. As the world’s leading vaccine manufacturer, our number one focus is to help develop a vaccine.
The collaboration for the first time brings together the scientific and manufacturing expertise and resources of two global scale vaccines specialists to address the urgent global need for a vaccine to protect people from this disease.
The two companies expect a candidate vaccine to enter clinical trials in the second half of 2020 and, if successful and subject to regulatory considerations, aim to complete the development required for availability by the second half of 2021.
Are you an aspiring enthusiast willing to develop a career in the medical sales field? The dynamic profile of a medical representative, their exponent...
A healthy gut indicates a healthy you! Isn't that true? In easy words, gut health refers to the balance of microorganisms present in your digestive sy...
Is the scorching sun heat taking a toll on your skin health? The summers trigger all skin types due to excessive humidity and heat around. Dermatologi...
